The Specific Heat of Matter at Low Temperatures

por Tari, A
Publicado 2003

De-escalating axillary surgery in early-stage breast cancer()

por Hersh, Eliza H., King, Tari A.
Publicado 2021

Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer

por Kantor, Olga, Wong, Stephanie, Weiss, Anna, Metzger, Otto, Mittendorf, Elizabeth A., King, Tari A.
Publicado 2020

Association Between Time to Operation and Pathologic Stage in Ductal Carcinoma in Situ and Early-Stage Hormone Receptor-Positive Breast Cancer

por Minami, Christina A., Kantor, Olga, Weiss, Anna, Nakhlis, Faina, King, Tari A., Mittendorf, Elizabeth A.
Publicado 2020

Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal car...

por Banerjee, R, Rachid, Z, Qiu, Q, McNamee, J P, Tari, A M, Jean-Claude, B J
Publicado 2004

The effect of metformin on breast cancer outcomes in patients with type 2 diabetes

por Oppong, Bridget A, Pharmer, Lindsay A, Oskar, Sabine, Eaton, Anne, Stempel, Michelle, Patil, Sujata, King, Tari A
Publicado 2014

Assessment of Oncologists’ Perspectives on Omission of Sentinel Lymph Node Biopsy in Women 70 Years and Older With Early-Stage Hormone Receptor–Positive Breast Cancer

por Minami, Christina A., Bryan, Ava F., Freedman, Rachel A., Revette, Anna C., Schonberg, Mara A., King, Tari A., Mittendorf, Elizabeth A.
Publicado 2022

Initiation and tolerance of chemoprevention among women with high-risk breast lesions: the potential of low-dose tamoxifen

por Bychkovsky, Brittany, Laws, Alison, Katlin, Fisher, Hans, Marybeth, Knust Graichen, Mary, Pace, Lydia E., Scheib, Rochelle, Garber, Judy E., King, Tari A.
Publicado 2022

Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions

por Andrade, Victor P, Ostrovnaya, Irina, Seshan, Venkatraman E, Morrogh, Mary, Giri, Dilip, Olvera, Narciso, De Brot, Marina, Morrow, Monica, Begg, Colin B, King, Tari A
Publicado 2012

Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS)

por Punglia, Rinaa S, Bifolck, Kaitlyn, Golshan, Mehra, Lehman, Constance, Collins, Laura, Polyak, Kornelia, Mittendorf, Elizabeth, Garber, Judy, Hwang, Shelley E, Schnitt, Stuart J, Partridge, Ann H, King, Tari A
Publicado 2018

Inequities in referrals to a breast cancer risk assessment and prevention clinic: a mixed methods study

por King, Claire B., Bychkovsky, Brittany L., Warner, Erica T., King, Tari A., Freedman, Rachel A., Mittendorf, Elizabeth A., Katlin, Fisher, Revette, Anna, Crookes, Danielle M., Maniar, Neil, Pace, Lydia E.
Publicado 2023

Weathering the Storm: Managing Older Adults With Breast Cancer Amid COVID-19 and Beyond

por Freedman, Rachel A, Sedrak, Mina S, Bellon, Jennifer R, Block, Caroline C, Lin, Nancy U, King, Tari A, Minami, Christina, VanderWalde, Noam, Jolly, Trevor A, Muss, Hyman B, Winer, Eric P
Publicado 2020

Clonal relationships between lobular carcinoma in situ and other breast malignancies

por Begg, Colin B., Ostrovnaya, Irina, Carniello, Jose V. Scarpa, Sakr, Rita A., Giri, Dilip, Towers, Russell, Schizas, Michail, De Brot, Marina, Andrade, Victor P., Mauguen, Audrey, Seshan, Venkatraman E., King, Tari A.
Publicado 2016

In situ single cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2(+) breast cancer

por Janiszewska, Michalina, Liu, Lin, Almendro, Vanessa, Kuang, Yanan, Paweletz, Cloud, Sakr, Rita A., Weigelt, Britta, Hanker, Ariella B., Chandarlapaty, Sarat, King, Tari A., Reis-Filho, Jorge S., Arteaga, Carlos L., Park, So Yeon, Michor, Franziska, Polyak, Kornelia
Publicado 2015

ESR1 ligand binding domain mutations in hormone-resistant breast cancer

por Toy, Weiyi, Shen, Yang, Won, Helen, Green, Bradley, Sakr, Rita A., Will, Marie, Li, Zhiqiang, Gala, Kinisha, Fanning, Sean, King, Tari A., Hudis, Clifford, Chen, David, Taran, Tetiana, Hortobagyi, Gabriel, Greene, Geoffrey, Berger, Michael, Baselga, Jose, Chandarlapaty, Sarat
Publicado 2013

Alcohol consumption and breast tumor gene expression

por Wang, Jun, Heng, Yujing J., Eliassen, A. Heather, Tamimi, Rulla M., Hazra, Aditi, Carey, Vincent J., Ambrosone, Christine B., de Andrade, Victor P., Brufsky, Adam, Couch, Fergus J., King, Tari A., Modugno, Francesmary, Vachon, Celine M., Hunter, David J., Beck, Andrew H., Hankinson, Susan E.
Publicado 2017

A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer

por Waks, Adrienne G., Desai, Neelam V., Li, Tianyu, Poorvu, Philip D., Partridge, Ann H., Sinclair, Natalie, Spring, Laura M., Faggen, Meredith, Constantine, Michael, Metzger, Otto, Alberti, Jillian, Deane, Julia, Rosenberg, Shoshana M., Frank, Elizabeth, Tolaney, Sara M., Krop, Ian E., Tung, Nadine M., Tayob, Nabihah, King, Tari A., Mittendorf, Elizabeth A., Winer, Eric P.
Publicado 2022

Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples

por Martelotto, Luciano G, Baslan, Timour, Kendall, Jude, Geyer, Felipe C, Burke, Kathleen A, Spraggon, Lee, Piscuoglio, Salvatore, Chadalavada, Kalyani, Nanjangud, Gouri, Ng, Charlotte KY, Moody, Pamela, D’Italia, Sean, Rodgers, Linda, Cox, Hilary, Paula, Arnaud da Cruz, Stepansky, Asya, Schizas, Michail, Wen, Hannah Y, King, Tari A, Norton, Larry, Weigelt, Britta, Hicks, James B, Reis-Filho, Jorge S
Publicado 2017

SET(ER/PR): a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancer

por Sinn, Bruno V., Fu, Chunxiao, Lau, Rosanna, Litton, Jennifer, Tsai, Tsung-Heng, Murthy, Rashmi, Tam, Alda, Andreopoulou, Eleni, Gong, Yun, Murthy, Ravi, Gould, Rebekah, Zhang, Ya, King, Tari A., Viale, Agnes, Andrade, Victor, Giri, Dilip, Salgado, Roberto, Laios, Ioanna, Sotiriou, Christos, Marginean, Esmeralda C., Kwiatkowski, Danielle N., Layman, Rachel M., Booser, Daniel, Hatzis, Christos, Vicente Valero, V., Fraser Symmans, W.
Publicado 2019

Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP

por Litton, Jennifer K., Regan, Meredith M., Pusztai, Lajos, Rugo, Hope S., Tolaney, Sara M., Garrett-Mayer, Elizabeth, Amiri-Kordestani, Laleh, Basho, Reva K., Best, Ana F., Boileau, Jean-Francois, Denkert, Carsten, Foster, Jared C., Harbeck, Nadia, Jacene, Heather A., King, Tari A., Mason, Ginny, O'Sullivan, Ciara C., Prowell, Tatiana M., Richardson, Andrea L., Sepulveda, Karla A., Smith, Mary Lou, Tjoe, Judy A., Turashvili, Gulisa, Woodward, Wendy A., Butler, Lynn Pearson, Schwartz, Elena I., Korde, Larissa A.
Publicado 2023